FY24 Funding, HHS
FY24 Funding, MilConVA
FY24 Funding, DOD
TB Elimination Legislation
Medical Research and Public Health Programs
Duration: January 1, 2008
to
present
General Issues: Budget/Appropriations , Health Issues
Spending: about $610,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: U.S. Senate, House of Representatives, Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Natl Institutes of Health (NIH)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
Health and Medicine Counsel, LLC amended a lobbying report for representation of AMERICAN THORACIC SOCIETY in Q12024 on April 16.
Original Filing: 301550952.xml
Lobbying Issues
FY24 Funding, HHS
FY24 Funding, MilConVA
FY24 Funding, DOD
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
TB Elimination Legislation
Medical Research and Public Health Programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2024
In Q1, Health and Medicine Counsel, LLC lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 4.
Original Filing: 301546490.xml
Lobbying Issues
FY24 Funding, HHS
FY24 Funding, MilConVA
FY24 Funding, DOD
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
TB Elimination Legislation
Medical Research and Public Health Programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2023
Health and Medicine Counsel, LLC amended a lobbying report for representation of AMERICAN THORACIC SOCIETY in Q42023 on April 17.
Original Filing: 301551802.xml
Lobbying Issues
FY24 Funding, HHS
FY24 Funding, MilConVA
FY24 Funding, DOD
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
TB Elimination Legislation
Medical Research and Public Health Programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2023
In Q4, Health and Medicine Counsel, LLC lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 3.
Original Filing: 301521497.xml
Lobbying Issues
FY24 Funding, HHS
FY24 Funding, MilConVA
FY24 Funding, DOD
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
TB Elimination Legislation
Medical Research and Public Health Programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2023
Health and Medicine Counsel, LLC amended a lobbying report for representation of AMERICAN THORACIC SOCIETY in Q32023 on April 17.
Original Filing: 301551912.xml
Lobbying Issues
FY24 Funding, HHS
FY24 Funding, MilConVA
FY24 Funding, DOD
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
TB Elimination Legislation
Medical Research and Public Health Programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2023
In Q3, Health and Medicine Counsel, LLC lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 4, 2023.
Original Filing: 301497604.xml
Lobbying Issues
FY24 Funding, HHS
FY24 Funding, MilConVA
FY24 Funding, DOD
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
TB Elimination Legislation
Medical Research and Public Health Programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2023
In Q2, Health and Medicine Counsel, LLC lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 6, 2023.
Original Filing: 301473346.xml
Lobbying Issues
FY24 Funding, HHS
FY24 Funding, MilConVA
FY24 Funding, DOD
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
TB Elimination Legislation
Medical Research and Public Health Programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2023
In Q1, Health and Medicine Counsel, LLC lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 6, 2023.
Original Filing: 301449279.xml
Lobbying Issues
FY24 Funding, HHS
FY24 Funding, MilConVA
FY24 Funding, DOD
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
TB Elimination Legislation
Medical Research and Public Health Programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2022
In Q4, Health and Medicine Counsel, LLC lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 1, 2023.
Original Filing: 301424393.xml
Lobbying Issues
FY22 L-HHS
FY22 Interior
FY22 MilCon-VA
FY22 State For. Ops.
FY22 Defense
FY22 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
Comprehensive TB Elimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2022
In Q3, Health and Medicine Counsel, LLC lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 5, 2022.
Original Filing: 301401391.xml
Lobbying Issues
FY22 L-HHS
FY22 Interior
FY22 MilCon-VA
FY22 State For. Ops.
FY22 Defense
FY22 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
Comprehensive TB Elimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2022
In Q2, Health and Medicine Counsel, LLC lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 12, 2022.
Original Filing: 301378952.xml
Lobbying Issues
FY22 L-HHS
FY22 Interior
FY22 MilCon-VA
FY22 State For. Ops.
FY22 Defense
FY22 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
Comprehensive TB Elimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2022
In Q1, Health and Medicine Counsel, LLC lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 14, 2022.
Original Filing: 301356086.xml
Lobbying Issues
FY22 L-HHS
FY22 Interior
FY22 MilCon-VA
FY22 State For. Ops.
FY22 Defense
FY22 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
Comprehensive TB Elimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2021
In Q4, Health and Medicine Counsel, LLC lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 14, 2022.
Original Filing: 301322416.xml
Lobbying Issues
FY22 L-HHS
FY22 Interior
FY22 MilCon-VA
FY22 State For. Ops.
FY22 Defense
FY22 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
Comprehensive TB Elimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2021
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 4, 2021.
Original Filing: 301296426.xml
Lobbying Issues
FY22 L-HHS
FY22 Interior
FY22 MilCon-VA
FY22 State For. Ops.
FY22 Defense
FY22 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
Comprehensive TB Elimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2021
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 7, 2021.
Original Filing: 301273873.xml
Lobbying Issues
FY22 L-HHS
FY22 Interior
FY22 MilCon-VA
FY22 State For. Ops.
FY22 Defense
FY22 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
Comprehensive TB Elimination Act
COVID-19 Relief Packages
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2021
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 7, 2021.
Original Filing: 301251097.xml
Lobbying Issues
FY22 L-HHS
FY22 Interior
FY22 MilCon-VA
FY22 State For. Ops.
FY22 Defense
FY22 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
CDC Chronic Disease Education and Awareness Program
Comprehensive TB Elimination Act
COVID-19 Relief Packages
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2020
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 13, 2021.
Original Filing: 301230341.xml
Lobbying Issues
FY21 L-HHS
FY21 Interior
FY21 MilCon-VA
FY21 State For. Ops.
FY21 Defense
FY21 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Comprehensive TB Elimination Act
COVID-19 Relief Packages
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2020
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 8, 2020.
Original Filing: 301208071.xml
Lobbying Issues
FY21 L-HHS
FY21 Interior
FY21 MilCon-VA
FY21 State For. Ops.
FY21 Defense
FY21 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Comprehensive TB Elimination Act
COVID-19 Relief Packages
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2020
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 7, 2020.
Original Filing: 301185601.xml
Lobbying Issues
FY21 L-HHS
FY21 Interior
FY21 MilCon-VA
FY21 State For. Ops.
FY21 Defense
FY21 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Comprehensive TB Elimination Act
COVID-19 Relief Packages
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2020
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 9, 2020.
Original Filing: 301154912.xml
Lobbying Issues
FY20 L-HHS
FY20 Interior
FY20 MilCon-VA
FY20 State For. Ops.
FY20 Defense
FY20 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Comprehensive TB Elimination Act
COVID-19 Relief Packages
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2019
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 14, 2020.
Original Filing: 301105270.xml
Lobbying Issues
FY20 L-HHS
FY20 Interior
FY20 MilCon-VA
FY20 State For. Ops.
FY20 Defense
FY20 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Pla
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Comprehensive TB Elimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2019
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 4, 2019.
Original Filing: 301063276.xml
Lobbying Issues
FY20 L-HHS
FY20 Interior
FY20 MilCon-VA
FY20 State For. Ops.
FY20 Defense
FY20 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Pla
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Comprehensive TB Elimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2019
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 9, 2019.
Original Filing: 301043751.xml
Lobbying Issues
FY20 L-HHS
FY20 Interior
FY20 MilCon-VA
FY20 State For. Ops.
FY20 Defense
FY20 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Pla
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Comprehensive TB Elimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2019
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 11, 2019.
Original Filing: 301024173.xml
Lobbying Issues
FY20 L-HHS
FY20 Interior
FY20 MilCon-VA
FY20 State For. Ops.
FY20 Defense
FY20 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Pla
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Comprehensive TB Elimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2018
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 7, 2019.
Original Filing: 301002445.xml
Lobbying Issues
FY19 L-HHS
FY19 Interior
FY19 MilCon-VA
FY19 State For. Ops.
FY19 Defense
FY19 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Comprehensive TB Elimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2018
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 10, 2018.
Original Filing: 300984005.xml
Lobbying Issues
FY19 L-HHS
FY19 Interior
FY19 MilCon-VA
FY19 State For. Ops.
FY19 Defense
FY19 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Comprehensive TB Elimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2018
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 11, 2018.
Original Filing: 300963578.xml
Lobbying Issues
FY19 L-HHS
FY19 Interior
FY19 MilCon-VA
FY19 State For. Ops.
FY19 Defense
FY19 Ag/FDA
Tuberculosis Control Reauthorization
National COPD Action Plan
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Comprehensive TB Elimination Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2018
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 11, 2018.
Original Filing: 300943679.xml
Lobbying Issues
FY18 L-HHS
FY18 Interior
FY18 MilCon-VA
FY18 State For. Ops.
FY18 Defense
FY18 Ag/FDA
Tuberculosis Control Reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2017
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 10, 2018.
Original Filing: 300922330.xml
Lobbying Issues
FY17 L-HHS
FY17 Interior
FY17 MilCon-VA
FY17 State For. Ops.
FY17 Defense
FY17 Ag/FDA
Tuberculosis Control Reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2017
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 6, 2017.
Original Filing: 300901696.xml
Lobbying Issues
FY17 L-HHS
FY17 Interior
FY17 MilCon-VA
FY17 State For. Ops.
FY17 Defense
FY17 Ag/FDA
Tuberculosis Control Reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2017
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 12, 2017.
Original Filing: 300883593.xml
Lobbying Issues
FY17 L-HHS
FY17 Interior
FY17 MilCon-VA
FY17 State For. Ops.
FY17 Defense
FY17 Ag/FDA
Tuberculosis Control Reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 294/H.R. 564: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2017
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 11, 2017.
Original Filing: 300863924.xml
Lobbying Issues
FY17 L-HHS
FY17 Interior
FY17 MilCon-VA
FY17 State For. Ops.
FY17 Defense
FY17 Ag/FDA
Tuberculosis Control Reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 441/H.R. 662: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2016
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 6, 2017.
Original Filing: 300843958.xml
Lobbying Issues
FY17 L-HHS
FY17 Interior
FY17 MilCon-VA
FY17 State For. Ops.
FY17 Defense
FY17 Ag/FDA
Tuberculosis Control Reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 441/H.R. 662: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2016
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 14, 2016.
Original Filing: 300827922.xml
Lobbying Issues
FY17 L-HHS
FY17 Interior
FY17 MilCon-VA
FY17 State For. Ops.
FY17 Defense
FY17 Ag/FDA
Tuberculosis Control Reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 441/H.R. 662: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2016
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 13, 2016.
Original Filing: 300808826.xml
Lobbying Issues
FY16 L-HHS
FY16 Interior
FY16 MilCon-VA
FY16 State For. Ops.
FY16 Defense
FY16 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 441/H.R. 662: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2016
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 7, 2016.
Original Filing: 300788811.xml
Lobbying Issues
FY16 L-HHS
FY16 Interior
FY16 MilCon-VA
FY16 State For. Ops.
FY16 Defense
FY16 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 441/H.R. 662: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2015
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 14, 2016.
Original Filing: 300771624.xml
Lobbying Issues
FY16 L-HHS
FY16 Interior
FY16 MilCon-VA
FY16 State For. Ops.
FY16 Defense
FY16 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 441/H.R. 662: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2015
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 14, 2015.
Original Filing: 300752766.xml
Lobbying Issues
FY16 L-HHS
FY16 Interior
FY16 MilCon-VA
FY16 State For. Ops.
FY16 Defense
FY16 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 441/H.R. 662: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2015
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 10, 2015.
Original Filing: 300733057.xml
Lobbying Issues
FY16 L-HHS
FY16 Interior
FY16 MilCon-VA
FY16 State For. Ops.
FY16 Defense
FY16 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 441/H.R. 662: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2015
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 13, 2015.
Original Filing: 300714442.xml
Lobbying Issues
FY16 L-HHS
FY16 Interior
FY16 MilCon-VA
FY16 State For. Ops.
FY16 Defense
FY16 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 441/H.R. 662: Traditional Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2014
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 16, 2015.
Original Filing: 300697625.xml
Lobbying Issues
FY15 L-HHS
FY15 Interior
FY15 MilCon-VA
FY15 State For. Ops.
FY15 Defense
FY15 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 772 / H.R.792: Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2014
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 17, 2014.
Original Filing: 300679107.xml
Lobbying Issues
FY15 L-HHS
FY15 Interior
FY15 MilCon-VA
FY15 State For. Ops.
FY15 Defense
FY15 Ag/FDA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 772 / H.R.792: Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2014
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 8, 2014.
Original Filing: 300653999.xml
Lobbying Issues
FY15 L-HHS
FY15 Interior
FY15 MilCon-VA
FY15 State For. Ops.FY15 Defense
FY15 Ag/FDA
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 772 / H.R.792: Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2014
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 16, 2014.
Original Filing: 300637657.xml
Lobbying Issues
FY14 & FY15 L-HHS
FY14 & FY15 Interior
FY14 & FY15 MilCon-VA
FY14 & FY15 State For. Ops.FY14 & FY15 Defense
FY14 & FY15 Ag/FDA
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
Lung Health (e.g. asthma, TB & COPD)
S. 772 / H.R.792: Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2013
HEALTH AND MEDICINE COUNSEL OF WASHINGTON amended a lobbying report for representation of AMERICAN THORACIC SOCIETY in Q42013 on Jan. 10, 2014.
Original Filing: 300614488.xml
Lobbying Issues
FY14 L-HHS
FY14 Interior
FY14 MilCon-VA
FY14 State For. Ops.FY14 Defense
FY14 Ag/FDA
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 1581 & S. 1020: Patient-focused Critical Care Enhancement Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic
obstructive pulmonary disease
Lung Health (e.g. asthma, TB & COPD)H.R. 6190: Asthma Inhalers Relief Act of 2012
H.R. 1639 & S. 1469: Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2013
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 9, 2013.
Original Filing: 300591556.xml
Lobbying Issues
FY14 L-HHS
FY14 Interior
FY14 MilCon-VA
FY14 State For. Ops.FY14 Defense
FY14 Ag/FDA
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 1581 & S. 1020: Patient-focused Critical Care Enhancement Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic
obstructive pulmonary disease
Lung Health (e.g. asthma, TB & COPD)H.R. 6190: Asthma Inhalers Relief Act of 2012
H.R. 1639 & S. 1469: Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2013
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 11, 2013.
Original Filing: 300570772.xml
Lobbying Issues
FY14 L-HHS
FY14 Interior
FY14 MilCon-VA
FY14 State For. Ops.FY14 Defense
FY14 Ag/FDA
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 1581 & S. 1020: Patient-focused Critical Care Enhancement Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic
obstructive pulmonary disease
Lung Health (e.g. asthma, TB & COPD)H.R. 6190: Asthma Inhalers Relief Act of 2012
H.R. 1639 & S. 1469: Cigar Manufacturing & Small Business Jobs Preservation Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2013
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 18, 2013.
Original Filing: 300552819.xml
Lobbying Issues
FY13 & 14 L-HHS
FY13 & 14 Interior
FY13 & 14 MilCon-VA
FY13 & 14 State For. Ops.FY13 & 14 Defense
FY 13 &14 Ag/FDA
FY13-CR
H.R. 8: American Taxpayer Relief Act of 2012
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 1581 & S. 1020: Patient-focused Critical Care Enhancement Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic
obstructive pulmonary disease
Lung Health (e.g. asthma, TB & COPD)S. 2057: A bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs
H.R. 6190: Asthma Inhalers Relief Act of 2012
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2012
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 15, 2013.
Original Filing: 300528648.xml
Lobbying Issues
FY13 L-HHS
FY13 Interior
FY13 MilCon-VA
FY13 State For. Ops.FY13 Defense
FY13 Ag/FDA
FY13-CR
H.R. 8: American Taxpayer Relief Act of 2012
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 1581 & S. 1020: Patient-focused Critical Care Enhancement Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic
obstructive pulmonary disease
Lung Health (e.g., asthma, TB & COPD)S. 2057: A bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs
H.R. 6190: Asthma Inhalers Relief Act of 2012
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2012
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 17, 2012.
Original Filing: 300508663.xml
Lobbying Issues
FY13 L-HHS
FY13 Interior
FY13 MilCon-VA
FY13 State For. OpsFY13 Defense
FY13 Ag/FDA
FY13-CR
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 1581 & S. 1020: Patient-focused Critical Care Enhancement Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Lung Health (e.g., asthma, TB & COPD)S. 2057: A bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs
H.R. 6190: Asthma Inhalers Relief Act of 2012
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2012
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 13, 2012.
Original Filing: 300483397.xml
Lobbying Issues
FY13 L-HHS
FY13 Interior
FY13 MilCon-VA
FY13 State For. Ops.FY13 Defense
FY13 Ag/FDA
FY13-CR
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 1581 & S. 1020: Patient-focused Critical Care Enhancement Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease.
Lung Health (e.g., asthma, TB & COPD)S. 2057: A bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2012
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 9, 2012.
Original Filing: 300458348.xml
Lobbying Issues
FY13 L-HHS
FY13 Interior
FY13 MilCon-VA
FY13 State For. OpsFY13 Defense
FY13 Ag/FDA
FY13-CR
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
H.R. 1581 & S. 1020: Patient-focused Critical Care Enhancement Act
H.R. 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic
obstructive pulmonary disease
Lung Health (e.g., asthma, TB & COPD)S. 2057: A bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
4th Quarter, 2011
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 12, 2012.
Original Filing: 300436226.xml
Lobbying Issues
FY12 L-HHS
FY12 Interior
FY12 MilCon-VA
FY12 State For. OpsFY12 Defense
FY12 Ag/FDA
FY12-CR
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
Lobbying Issues
HR 1581 & S 1020: Patient-focused Critical Care Enhancement Act
HR 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Lung Health (eg, asthma, TB & COPD)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
3rd Quarter, 2011
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 13, 2011.
Original Filing: 300413284.xml
Lobbying Issues
FY12 L-HHS
FY12 Interior
FY12 MilCon-VA
FY12 State For. OpsFY11 DoD Bill
FY12 Defense
HR 1475-CR (FY11)
FY12 Ag/FDA
FY12-CR
HR 2954: Health Equity Accountability Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
Lobbying Issues
HR 1581 & S 1020: Patient-focused Critical Care Enhancement Act
HR 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Lung Health (eg, asthma, TB & COPD)HR 2954: Health Equity Accountability Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
2nd Quarter, 2011
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 13, 2011.
Original Filing: 300389005.xml
Lobbying Issues
FY12 L-HHS
FY12 Interior
FY12 MilCon-VA
FY12 State For. OpsFY11 DoD Bill
FY12 Defense
HR 1475-CR (FY11)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
Lobbying Issues
HR 1581 & S 1020: Patient-focused Critical Care Enhancement Act
HR 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Lung Health (eg, asthma, TB & COPD)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
1st Quarter, 2011
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 14, 2011.
Original Filing: 300364188.xml
Lobbying Issues
FY11 Labor-HHS Appropriations Bill
FY11 VA Bill
FY12 L-HHS
FY12 InteriorFY11 DoD Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1581 & S 1020: Patient-focused Critical Care Enhancement Act
HR 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2010
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 20, 2011.
Original Filing: 300350179.xml
Lobbying Issues
FY11 Labor-HHS Appropriations Bill
FY11 Interior Bill
FY11 VA Bill
FY11 Foreign Operations BillFY 11 DoD Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1581 & S 1020: Patient-focused Critical Care Enhancement Act
HR 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2010
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 8, 2010.
Original Filing: 300309928.xml
Lobbying Issues
FY11 Labor-HHS Appropriations Bill
FY11 Interior Bill
FY11 VA Bill
FY11 Foreign Operations BillFY11 DoD Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1581 & S 1020: Patient-focused Critical Care Enhancement Act
HR 5996: To direct the Secretary of Veterans Affairs to improve the prevention, diagnosis, and treatment of veterans with chronic obstructive pulmonary disease
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2010
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 13, 2010.
Original Filing: 300284641.xml
Lobbying Issues
FY11 Labor-HHS Appropriations Bill
FY11 Interior Bill
FY11 VA Bill
FY11 Foreign Operations BillFY 11 Defense Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1581 & S 1020: Patient-focused Critical Care Enhancement Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2010
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 15, 2010.
Original Filing: 300259080.xml
Lobbying Issues
FY11 Labor-HHS Appropriations Bill
FY11 Interior Bill
FY11 VA Bill
FY11 Foreign Operations BillFY11 Defense Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 1581 & S. 1020: Patient-focused Critical Care Enhancement Act
H.R. 3962: Affordable Health Care for America Act
H.R. 3590: Patient Protection and Affordable Care Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2009
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Jan. 7, 2010.
Original Filing: 300227886.xml
Lobbying Issues
FY10 Labor-HHS Bill
FY10 Interior Bill
FY10 VA Bill
FY10 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1581 & S 1020: Patient-focused Critical Care Enhancement Act
HR 3962: Affordable Health Care for American Act
HR 3590: Patient Protection and Affordable Care Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2009
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on Oct. 2, 2009.
Original Filing: 300200269.xml
Lobbying Issues
FY10 Labor-HHS Bill
FY10 Interior Bill
FY10 VA Bill
FY10 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1256 & S 982: Family Smoking Prevention and Tobacco Control Act
HR 1: American Recovery and Reinvestment Act
HR 1581 & S 1020: Patient-focused Critical Care Enhancemeny Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2009
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on July 7, 2009.
Original Filing: 300173134.xml
Lobbying Issues
FY10 Labor-HHS Bill
FY10 Interior Bill
FY10 VA Bill
FY10 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1256 & S 982: Family Smoking Prevention and Tobacco Control Act
HR 1: American Recovery and Reinvestment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2009
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY , earning $10,000. The report was filed on April 20, 2009.
Original Filing: 300157414.xml
Lobbying Issues
FY 10 Labor-HHS Bill
FY 10 Interior Bill
FY 10 VA Bill
FY 10 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1256: Family Smoking Prevention and Tobacco Control Act
HR 1: American Recovery and Reinvestment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2008
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY . The report was filed on Jan. 21, 2009.
Original Filing: 300129616.xml
Lobbying Issues
FY 09 Labor-HHS Bill
FY 09 Interior Bill
FY 09 VA Bill
FY 09 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 1567/ S. 968: Foreign TB Bill
H.R. 1532/ S. 1551: Domestic TB Bill
H.R. 1108/ S. 625: Family Smoking Prevention & Tobacco Control Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2008
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY . The report was filed on Oct. 20, 2008.
Original Filing: 300102997.xml
Lobbying Issues
FY 09 Labor-HHS Bill
FY 09 Interior Bill
FY 09 VA Bill
FY 09 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR. 1567/ S. 968: Foreign TB Bill
HR. 1532/ S. 1551: Domestic TB Bill
HR. 1108/ S. 625: Family Smoking Prevention & Tobacco Control Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2008
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY . The report was filed on July 21, 2008.
Original Filing: 300077025.xml
Lobbying Issues
FY 09 Labor-HHS Bill
FY 09 Interior Bill
FY 09 VA Bill
FY 09 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1567/ S 968: Foreign TB Bill
HR 1532/ S 1551: Domestic TB Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2008
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for AMERICAN THORACIC SOCIETY . The report was filed on April 18, 2008.
Original Filing: 300044171.xml
Lobbying Issues
FY 09 Labor-HHS Bill
FY 09 Interior Bill
FY 09 VA Bill
FY 09 Foreign Operations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1567/S. 968: Foreign TB Bills
HR 1532/S. 1551: Domestic TB Bills
S. 1966: PEPFAR Reauthorization
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate